Compounds > tolvaptan
Page last updated: 2024-09-05

tolvaptan and simendan

tolvaptan has been researched along with simendan in 4 studies

Compound Research Comparison

Studies
(tolvaptan)		Trials
(tolvaptan)		Recent Studies (post-2010)
(tolvaptan)		Studies
(simendan)		Trials
(simendan)		Recent Studies (post-2010) (simendan)
9671727861,305255648

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gheorghiade, M; Mebazaa, A; Teerlink, JR1
Francis, GS; Unzek, S1
Ambrosy, AP; Butler, J; Gheorghiade, M; Greene, SJ; Vaduganathan, M1
Chivite, D; Corbella, X; Formiga, F1

Reviews

4 review(s) available for tolvaptan and simendan

ArticleYear
Pharmacology of new agents for acute heart failure syndromes.
    The American journal of cardiology, 2005, Sep-19, Volume: 96, Issue:6A

    Topics: Acute Disease; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cardiotonic Agents; Clinical Trials as Topic; Endothelin Receptor Antagonists; Heart Failure; Humans; Hydrazones; Pyridazines; Pyridines; Simendan; Syndrome; Tetrazoles; Tolvaptan; Vasodilator Agents

2005
Management of heart failure: a brief review and selected update.
    Cardiology clinics, 2008, Volume: 26, Issue:4

    Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cardiotonic Agents; Diuretics; Heart Failure; Hemofiltration; Humans; Hydrazones; Natriuretic Peptide, Brain; Pacemaker, Artificial; Pyridazines; Simendan; Tolvaptan; Vasodilator Agents

2008
The disconnect between phase II and phase III trials of drugs for heart failure.
    Nature reviews. Cardiology, 2013, Volume: 10, Issue:2

    Topics: Animals; Benzazepines; Cardiovascular Agents; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Evidence-Based Medicine; Heart Failure; Humans; Hydrazones; Natriuretic Peptide, Brain; Patient Readmission; Patient Selection; Pyridazines; Pyridines; Risk Assessment; Risk Factors; Simendan; Tetrazoles; Time Factors; Tolvaptan; Treatment Outcome; Xanthines

2013
[Organ-protection therapy. A new therapeutic approach for acute heart failure?].
    Medicina clinica, 2014, Volume: 142 Suppl 1

    Topics: Acute Disease; Amides; Benzazepines; Cardio-Renal Syndrome; Dobutamine; Fumarates; Heart Failure; Humans; Hydrazones; Inflammation; Kaplan-Meier Estimate; Multicenter Studies as Topic; Natriuretic Peptide, Brain; Prognosis; Pyridazines; Randomized Controlled Trials as Topic; Recombinant Proteins; Relaxin; Simendan; Therapies, Investigational; Tolvaptan

2014